Mito Securities sets JPY 2,050 target for Dai-ichi Life stock

Published on 10/20/2026 at 19:18 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Dai-ichi Life schedules half-year results for November 13, 2026. Dai-ichi Life stock costs EUR 10.18 on October 20, 2026 at 7:09 p.m. CEST.

Analyst target and reporting date

Mito Securities set a JPY 2,050 target for Dai-ichi Life on October 9, 2026.
Dai-ichi Life scheduled its six-month results for November 13, 2026.
Dai-ichi Life stock costs EUR 10.18 at Lang & Schwarz on October 20, 2026 at 7:09 p.m. CEST.

Dai-ichi Life, JP3476480003, Illustration mit AI erstellt.

Dai-ichi Life (ISIN JP3476480003) received a JPY 2,050 price target from Mito Securities on October 9, 2026, when the research firm started coverage with a Neutral Plus rating, MarketScreener reported. The target is 14.21 percent above the JPY 1,795 last traded price on the Tokyo market on October 20, 2026. Dai-ichi Life stock was trading at EUR 10.18 at Lang & Schwarz on October 20, 2026 at 7:09 p.m. CEST.

The target leaves room above the price

The target comparison gives investors a clear valuation marker in the home market. Mito Securities assigned the Neutral Plus view alongside the JPY 2,050 target, while the same-day Tokyo quotation stood at JPY 1,795. The difference is 14.21 percent, calculated against that JPY 1,795 price.

For fiscal year 2026, which ended March 31, 2026, net income attributable to owners of the parent was JPY 436.6 billion, down from JPY 458.4 billion in fiscal year 2025, according to KabuFacts. The 4.76 percent decline contrasts with the insurer's JPY 2,050 research target and keeps earnings quality relevant to the valuation discussion.

Stock range and valuation markers

Dai-ichi Life's 52-week range was JPY 1,052.00 to JPY 1,959.00 as of October 20, 2026. Its market capitalization was JPY 6.5 trillion, its price-to-earnings ratio was 11.77, and the quoted dividend yield was 0.04 percent on the same date.

What comes next for investors?

The next scheduled corporate milestone is the six-month results release on November 13, 2026, according to KabuFacts. The company is expected to report results for the six months ended September 30, 2026. Separately, on October 19, 2026, Daiichi Life said that no legally binding transaction had been decided regarding media reports about a proposal involving Challenger, according to Japan IR.

Price and upcoming results

The analyst target, the JPY 436.6 billion fiscal-year net income and the November 13, 2026 reporting date give the stock three concrete reference points. The euro quotation stood at EUR 10.18 at Lang & Schwarz on October 20, 2026 at 7:09 p.m. CEST.

The further course of trading is shown by the continuously updated real-time quote of Dai-ichi Life stock.